From monocyte‐derived macrophages to resident macrophages—how metabolism leads their way in cancer

Ummi Ammarah,Andreia Pereira‐Nunes,Marcello Delfini,Massimiliano Mazzone

DOI: https://doi.org/10.1002/1878-0261.13618

2024-02-29

Molecular Oncology

Abstract:Tumor‐associated macrophages (TAMs) constitute up to 50% of the tumor mass, representing a heterogeneous population of tissue‐resident and monocyte‐derived macrophages. TAM phenotype not only involves alterations in cell metabolism but also metabolic reprogramming that can dictate their activation state and function. This review elucidates the diverse roles and metabolic traits of distinct TAM subsets in pancreatic, breast, lung and ovarian malignancies. Macrophages are innate immune cells that play key roles during both homeostasis and disease. Depending on the microenvironmental cues sensed in different tissues, macrophages are known to acquire specific phenotypes and exhibit unique features that, ultimately, orchestrate tissue homeostasis, defense, and repair. Within the tumor microenvironment, macrophages are referred to as tumor‐associated macrophages (TAMs) and constitute a heterogeneous population. Like their tissue resident counterpart, TAMs are plastic and can switch function and phenotype according to the niche‐derived stimuli sensed. While changes in TAM phenotype are known to be accompanied by adaptive alterations in their cell metabolism, it is reported that metabolic reprogramming of macrophages can dictate their activation state and function. In line with these observations, recent research efforts have been focused on defining the metabolic traits of TAM subsets in different tumor malignancies and understanding their role in cancer progression and metastasis formation. This knowledge will pave the way to novel therapeutic strategies tailored to cancer subtype‐specific metabolic landscapes. This review outlines the metabolic characteristics of distinct TAM subsets and their implications in tumorigenesis across multiple cancer types.

oncology